Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Haleon Plc (HLN)

Haleon Plc (HLN)
10.15 x 1 10.55 x 1
Post-market by (Cboe BZX)
10.28 -0.11 (-1.06%) 03/21/25 [NYSE]
10.15 x 1 10.55 x 1
Post-market 10.28 unch (unch) 16:01 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
10.26
Day High
10.36
Open 10.29
Previous Close 10.39 10.39
Volume 9,109,200 9,109,200
Avg Vol 10,744,655 10,744,655
Stochastic %K 43.16% 43.16%
Weighted Alpha +22.20 +22.20
5-Day Change +0.13 (+1.28%) +0.13 (+1.28%)
52-Week Range 7.99 - 10.80 7.99 - 10.80
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,538,312
  • Shares Outstanding, K 4,527,073
  • Annual Sales, $ 14,355 M
  • Annual Income, $ 1,843 M
  • EBIT $ 1,748 M
  • EBITDA $ 3,233 M
  • 60-Month Beta 0.25
  • Price/Sales 3.28
  • Price/Cash Flow 20.84
  • Price/Book 2.27

Options Overview Details

View History
  • Implied Volatility 26.41% ( -0.86%)
  • Historical Volatility 26.36%
  • IV Percentile 19%
  • IV Rank 11.73%
  • IV High 108.59% on 08/05/24
  • IV Low 15.49% on 08/28/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 92
  • Volume Avg (30-Day) 133
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 3,513
  • Open Int (30-Day) 2,615

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.12
  • Growth Rate Est. (year over year) +832,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.66 +6.42%
on 02/27/25
Period Open: 10.08
10.79 -4.73%
on 03/04/25
+0.20 (+1.98%)
since 02/21/25
3-Month
8.86 +16.03%
on 01/14/25
Period Open: 9.69
10.79 -4.73%
on 03/04/25
+0.59 (+6.09%)
since 12/20/24
52-Week
7.99 +28.66%
on 04/12/24
Period Open: 8.33
10.80 -4.81%
on 09/27/24
+1.95 (+23.41%)
since 03/21/24

Most Recent Stories

More News
GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below. The stock has...

NVO : 76.86 (-2.45%)
LLY : 837.57 (-0.59%)
HLN : 10.28 (-1.06%)
GSK : 39.24 (-0.43%)
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon, or approximately...

JNJ : 163.63 (+0.37%)
HLN : 10.28 (-1.06%)
GSK : 39.24 (-0.43%)
PFE : 26.28 (+0.34%)
GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?

GSK GSK stock has declined 20.2% in the past three months compared with a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the chart below....

HLN : 10.28 (-1.06%)
MRNA : 32.66 (+0.65%)
GSK : 39.24 (-0.43%)
SNY : 56.90 (-1.54%)
The Hidden Power Of Spinoffs: Why They Continue To Outperform

CVS just announced it was considering a breakup. Why is that important? Spinoffs are one of the best-kept investment secrets, despite the fact that many investors typically disregard them and frequently...

PYPL : 70.19 (+0.75%)
CVS : 67.05 (-2.32%)
MDLZ : 64.51 (+0.88%)
TRIP : 14.89 (-0.60%)
COP : 101.92 (-0.38%)
KHC : 29.52 (-0.64%)
EXPE : 173.81 (+0.42%)
HLN : 10.28 (-1.06%)
PFE : 26.28 (+0.34%)
PSX : 125.49 (-2.59%)
EBAY : 65.78 (-0.84%)
VTRS : 9.15 (-3.07%)
4 Reasons Pfizer Could Be a Value Play You Can't Miss

Pfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) sent shares surging up to $61.71

HLN : 10.28 (-1.06%)
PFE : 26.28 (+0.34%)
BNTX : 95.38 (-0.88%)
You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over...

GSK : 39.24 (-0.43%)
HLN : 10.28 (-1.06%)
PFE : 26.28 (+0.34%)
JNJ : 163.63 (+0.37%)
KVUE : 23.31 (-0.34%)
SNY : 56.90 (-1.54%)
GSK Stock Gains 18.5% Year to Date: Time to Buy, Sell or Hold?

GSK GSK  stock has risen 18.5% so far this year compared with an increase of 27.1% for the industry. The stock has also been consistently trading above its 50-day and 200-day moving averages since mid-August.GSK...

GSK : 39.24 (-0.43%)
NVO : 76.86 (-2.45%)
LLY : 837.57 (-0.59%)
HLN : 10.28 (-1.06%)
1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

GSK : 39.24 (-0.43%)
HLN : 10.28 (-1.06%)
1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach...

MRNA : 32.66 (+0.65%)
GSK : 39.24 (-0.43%)
HLN : 10.28 (-1.06%)
CVS : 67.05 (-2.32%)
An Under the Radar Healthcare Stock to Add to Your Portfolio

The era of the giant pharmaceutical conglomerate is coming to a close, but consumer-focused Haleon stock looks set to deliver healthy returns through long-term economic cycles.

HLN : 10.28 (-1.06%)
GSK : 39.24 (-0.43%)
PFE : 26.28 (+0.34%)
NVS : 112.13 (-0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and...

See More

Key Turning Points

3rd Resistance Point 10.44
2nd Resistance Point 10.40
1st Resistance Point 10.34
Last Price 10.28
1st Support Level 10.24
2nd Support Level 10.20
3rd Support Level 10.14

See More

52-Week High 10.80
Last Price 10.28
Fibonacci 61.8% 9.73
Fibonacci 50% 9.40
Fibonacci 38.2% 9.06
52-Week Low 7.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals